New CEOs at Dunad and Cargene

Pearl Huang became CEO at Dunad Therapeutics Ltd. Huang joins from Cygnal Therapeutics, where she was president and CEO. She also held senior roles at Roche (SIX:ROG; OTCQX:RHHBY), GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) and Merck & Co. Inc. (NYSE:MRK). Dunad is developing small molecule covalent therapies for protein degradation. 

Kathy He joined Cargene Biopharma Inc. as CEO and a director. She was global CBO and general manager of China at Kira Pharmaceuticals Ltd...